APM
Aptorum Group Limited
NASDAQ · Healthcare · Biotechnology · GB
$8.26
−14.84%Margins
Gross margin
100.0%
EBITDA margin
-689.2%
EBIT margin
-660.3%
Net margin
-664.8%
FCF margin
-191.1%
—
Return on equity
-37.3%
Return on assets
-178.4%
Return on invested capital
0.05x
Asset turnover
-$1.8M
Cash from operations
$0.23
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026